Arbutus Biopharma Corp (ABUS)

EBITDA Growth

-299.61%

Quarterly · Period ending:

ABUS logo

ABUS EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-299.61%
ABUS Quarterly EBITDA YoY % (-1802.08% → -299.61%)
High-resolution chart · PNG

ABUS ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp EBITDA Growth — Quarterly
Period endingEBITDA Growth
-299.6097%
802.2633%
75.6961%
60.1695%
113.2021%
-38.2925%
23.9373%
1.7116%
-17.0376%
-10.5586%
2.3491%
-17.2313%
-24.4166%
-51.6841%
-2.3295%
6.4293%
23.8979%
31.005%
-28.5997%
-4.4093%
-40.2419%
-22.5974%
-23.7596%
81.6241%
45.2517%
45.7985%
28.0656%
-231.0638%
-20.7603%
-35.9206%
70.4094%
-158.5125%
-6.664%
8.3721%
-212.0729%
43.3744%
5.1682%
-16.5677%
-291.7077%
-35.0402%
-34.2151%
-82.2489%
54.1847%
-113.0085%
-50.0108%
-47.5103%
-361.3871%
-91.5786%
-217.7115%
-105.9406%
59.912%
-121.2233%
-25.9925%
-17.8533%
-153.4656%
-15.0417%
33.6902%
17.8138%
70.507%
36.2968%
-4.5174%
25.3265%
-286.9836%
-15.0365%
-130.6138%
-188.7057%
-679.1552%
14.8302%
70.1781%
-91.1536%
106.955%
-225.883%
-1,802.0764%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.